Effect of short-term oral and inhaled corticosteroids on airway inflammation and responsiveness in a feline acute asthma model

Veterinary Journal

Volumn 192, Issue 1, 2012, Pages 41-48

  Leemans, Jérôme ^a,b   Kirschvink, Nathalie ^b   Clercx, Cécile ^a   Snaps, Frédéric ^a   Gustin, Pascal ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF NAMUR   (Belgium)

Author keywords

Acute asthma; Airway responsiveness; Cat; Eosinophilic bronchial inflammation; Inhaled corticosteroids

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ASCARIS ANTIGEN; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; GELATINASE A; GELATINASE B; PREDNISOLONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

AIRWAY OBSTRUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BREATHING RATE; CAT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOLOGY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; ENZYME BLOOD LEVEL; EOSINOPHIL COUNT; FEMALE; LUNG FUNCTION; LUNG LAVAGE; MALE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PROSPECTIVE STUDY; RESPIRATORY TRACT INFLAMMATION; RESPONSE VARIABLE; SHORT COURSE THERAPY; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ALBUTEROL; ALLERGENS; ANDROSTADIENES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, HELMINTH; ASCARIS SUUM; ASTHMA; BRONCHODILATOR AGENTS; CAT DISEASES; CATS; CROSS-OVER STUDIES; DRUG COMBINATIONS; FEMALE; MALE; PREDNISOLONE; PROSPECTIVE STUDIES;

ANIMALIA; ASCARIS SUUM; FELIDAE;

EID: 84859487770     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2011.01.020     Document Type: Article

References (52)

1. Belda J., Margarit G., Martinez C., Bellido-Casado J., Casan P., Torrejon M., Brufal M., Rodriguez-Jerez F., Sanchis J. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations. European Respiratory Journal 2007, 30:1143-1149.
2. Bolton P.B., Lefevre P., McDonald D.M. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways. American Journal of Respiratory and Critical Care Medicine 1997, 155:1428-1435.
3. Cataldo D.D., Tournoy K.G., Vermaelen K., Munaut C., Foidart J.M., Louis R., Noel A., Pauwels R.A. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. American Journal of Pathology 2002, 161:491-498.
4. Cohn L.A., Declue A.E., Cohen R.L., Reinero C.R. Effects of fluticasone propionate dosage in an experimental model of feline asthma. Journal of Feline Medicine and Surgery 2010, 12:91-96.
5. Corcoran B.M., Foster D.J., Fuentes V.L. Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. Journal of Small Animal Practice 1995, 36:481-488.
6. Corry D.B., Kiss A., Song L.Z., Song L., Xu J., Lee S.H., Werb Z., Kheradmand F. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB Journal 2004, 18:995-997.
7. Delclaux C., Delacourt C., D'Ortho M.P., Boyer V., Lafuma C., Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. American Journal of Respiratory Cell and Molecular Biology 1996, 14:288-295.
8. Demedts I.K., Brusselle G.G., Bracke K.R., Vermaelen K.Y., Pauwels R.A. Matrix metalloproteinases in asthma and COPD. Current Opinion in Pharmacology 2005, 5:257-263.
9. Dente F.L., Bancalari L., Bacci E., Bartoli M.L., Carnevali S., Cianchetti S., Di F.A., Giannini D., Vagaggini B., Testi R., Paggiaro P.L. Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects. Thorax 1999, 54:622-624.
10. Di Franco A., Bacci E., Bartoli M.L., Cianchetti S., Dente F.L., Taccola M., Vagaggini B., Zingoni M., Paggiaro P.L. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization. Pulmonary Pharmacology and Therapeutics 2006, 19:353-360.
11. Dye J.A., McKiernan B.C., Rozanski E.A., Hoffmann W.E., Losonsky J.M., Homco L.D., Weisiger R.M., Kakoma I. Bronchopulmonary disease in the cat: historical, physical, radiographic, clinicopathologic, and pulmonary functional evaluation of 24 affected and 15 healthy cats. Journal of Veterinary Internal Medicine 1996, 10:385-400.
12. Eickelberg O., Roth M., Lorx R., Bruce V., Rudiger J., Johnson M., Block L.H. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. Journal of Biological Chemistry 1999, 274:1005-1010.
13. Ezeamuzie C.I., Ziada G., Mathew M., Philips E., Gopinath S., Owunwanne A. Eosinophils as a direct target of the anti-inflammatory effect of salmeterol: Demonstration with indium-111-labeled eosinophils. Medical Principles and Practice 2001, 10:83-88.
14. Foster S.F., Allan G.S., Martin P., Robertson I.D., Malik R. Twenty-five cases of feline bronchial disease (1995-2000). Journal of Feline Medicine and Surgery 2004, 6:181-188.
15. Foster S.F., Martin P., Braddock J.A., Malik R. A retrospective analysis of feline bronchoalveolar lavage cytology and microbiology (1995-2000). Journal of Feline Medicine and Surgery 2004, 6:189-198.
16. Gueders M.M., Foidart J.M., Noel A., Cataldo D.D. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. European Journal of Pharmacology 2006, 533:133-144.
17. Hawkins E.C., Kennedy-Stoskopf S., Levy J., Meuten D.J., Cullins L., DeNicola D., Tompkins W.A., Tompkins M.B. Cytologic characterization of bronchoalveolar lavage fluid collected through an endotracheal tube in cats. American Journal of Veterinary Research 1994, 55:795-802.
18. Hoshino M., Takahashi M., Takai Y., Sim J. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. Journal of Allergy and Clinical Immunology 1999, 104:356-363.
19. Kirschvink N., Leemans J., Delvaux F., Snaps F., Marlin D., Sparkes A., Clercx C., Gustin P. Non-invasive assessment of growth, gender and time of day related changes of respiratory pattern in healthy cats by use of barometric whole body plethysmography. The Veterinary Journal 2006, 172:446-454.
20. Kirschvink N., Kersnak E., Leemans J., Delvaux F., Clercx C., Snaps F., Gustin P. Effects of age and allergen-induced airway inflammation in cats: radiographic and cytologic correlation. The Veterinary Journal 2007, 174:644-651.
21. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., Gustin P. Functional, inflammatory and morphological characterisation of a cat model of allergic airway inflammation. The Veterinary Journal 2007, 174:541-553.
22. Kirschvink N., Leemans J., Delvaux F., Snaps F., Clercx C., Gustin P. Non-invasive assessment of airway responsiveness in healthy and allergen-sensitised cats by use of barometric whole body plethysmography. The Veterinary Journal 2007, 173:343-352.
23. Kumagai K., Ohno I., Okada S., Ohkawara Y., Suzuki K., Shinya T., Nagase H., Iwata K., Shirato K. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. Journal of Immunology 1999, 162:4212-4219.
24. Lee Y.C., Lee H.B., Rhee Y.K., Song C.H. The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma. Clinical and Experimental Allergy 2001, 31:1623-1630.
25. Lee K.S., Jin S.M., Kim S.S., Lee Y.C. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. Journal of Allergy and Clinical Immunology 2004, 113:902-909.
26. Leemans, J., Kirschvink, N., Billen, F., Clercx, C., Gustin, P., 2007. Effects of age and Ascaris suum aerosol exposure on the pro- and antigelatinolytic activity in serum and airways of cats. In: Proceedings of The 17th Congress of the European College of Veterinary Internal Medicine, Companion Animals, Budapest, Hungary, p. 236.
27. Leemans J., Kirschvink N., Bernaerts F., Clercx C., Cambier C., Gustin P. A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats. The Veterinary Journal 2009, 180:236-245.
28. Leemans J., Kirschvink N., Clercx C., Cambier C., Gustin P. Functional response to inhaled salbutamol and/or ipratropium bromide in Ascaris suum-sensitised cats with allergen-induced bronchospasms. The Veterinary Journal 2010, 186:76-83.
29. Leppert D., Hauser S.L., Kishiyama J.L., An S., Zeng L., Goetzl E.J. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB Journal 1995, 9:1473-1481.
30. Leppert D., Waubant E., Galardy R., Bunnett N.W., Hauser S.L. T cell gelatinases mediate basement membrane transmigration in vitro. Journal of Immunology 1995, 154:4379-4389.
31. Lowe A.D., Campbell K.L., Graves T. Glucocorticoids in the cat. Veterinary Dermatology 2008, 19:340-347.
32. Mautino G., Oliver N., Chanez P., Bousquet J., Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. American Journal of Respiratory Cell and Molecular Biology 1997, 17:583-591.
33. Moise N.S., Wiedenkeller D., Yeager A.E., Blue J.T., Scarlett J. Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). Journal of the American Veterinary Medical Association 1989, 194:1467-1473.
34. Norris Reinero C.R., Decile K.C., Berghaus R.D., Williams K.J., Leutenegger C.M., Walby W.F., Schelegle E.S., Hyde D.M., Gershwin L.J. An experimental model of allergic asthma in cats sensitized to house dust mite or Bermuda grass allergen. International Archives of Allergy and Immunology 2004, 135:117-131.
35. Okada S., Kita H., George T.J., Gleich G.J., Leiferman K.M. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. American Journal of Respiratory Cell and Molecular Biology 1997, 17:519-528.
36. Padrid P.A., Feldman B.F., Funk K., Samitz E.M., Reil D., Cross C.E. Cytologic, microbiologic, and biochemical analysis of bronchoalveolar lavage fluid obtained from 24 healthy cats. American Journal of Veterinary Research 1991, 52:1300-1307.
37. Padrid P., Snook S., Finucane T., Shiue P., Cozzi P., Solway J., Leff A.R. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. American Journal of Respiratory and Critical Care Medicine 1995, 151:184-193.
38. Palmqvist M., Persson G., Lazer L., Rosenborg J., Larsson P., Lotvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. European Respiratory Journal 1997, 10:2484-2489.
39. Pizzichini M.M., Pizzichini E., Clelland L., Efthimiadis A., Mahony J., Dolovich J., Hargreave F.E. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. American Journal of Respiratory and Critical Care Medicine 1997, 155:1501-1508.
40. Reinero C.R., Decile K.C., Byerly J.R., Berghaus R.D., Walby W.E., Berghaus L.J., Hyde D.M., Schelegle E.S., Gershwin L.J. Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. American Journal of Veterinary Research 2005, 66:1121-1127.
41. Reinero C.R., Brownlee L., Decile K.C., Seguin B., Berghaus R.D., Nelson R.W., Gershwin L.J. Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. Journal of Veterinary Internal Medicine 2006, 20:57-64.
42. Rodrigo G.J. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma. American Journal of Respiratory and Critical Care Medicine 2005, 171:1231-1236.
43. Rozanski E.A., Hoffman A.M. Lung function and inhaled albuterol in cats with asthma. Journal of Veterinary Internal Medicine 1999, 13:259.
44. Rush B.R., Hoskinson J.J., Davis E.G., Matson C.J., Hakala J.E. Pulmonary distribution of aerosolized technetium Tc 99m pentetate after administration of a single dose of aerosolized albuterol sulfate in horses with recurrent airway obstruction. American Journal of Veterinary Research 1999, 60:764-769.
45. Sugita M., Kuribayashi K., Nakagomi T., Miyata S., Matsuyama T., Kitada O. Allergic bronchial asthma: airway inflammation and hyperresponsiveness. Internal Medicine 2003, 42:636-643.
46. Tanaka H., Miyazaki N., Oashi K., Tanaka S., Ohmichi M., Abe S. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. Journal of Allergy and Clinical Immunology 2000, 105:900-905.
47. Tang M.L., Wilson J.W., Stewart A.G., Royce S.G. Airway remodelling in asthma: current understanding and implications for future therapies. Pharmacology and Therapeutics 2006, 112:474-488.
48. Tattersfield A.E., Postma D.S., Barnes P.J., Svensson K., Bauer C.A., O'Byrne P.M., Lofdahl C.G., Pauwels R.A., Ullman A. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. American Journal of Respiratory and Critical Care Medicine 1999, 160:594-599.
49. Usmani O.S., Ito K., Maneechotesuwan K., Ito M., Johnson M., Barnes P.J., Adcock I.M. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. American Journal of Respiratory and Critical Care Medicine 2005, 172:704-712.
50. van Noord J.A., Smeets J.J., Raaijmakers J.A., Bommer A.M., Maesen F.P. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. European Respiratory Journal 1996, 9:1684-1688.
51. Verberne A.A., Hop W.C., Bos A.B., Kerrebijn K.F. Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. Journal of Allergy and Clinical Immunology 1993, 91:127-134.
52. Whelan C.J., Johnson M. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. British Journal of Pharmacology 1992, 105:831-838.